These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 12011456)

  • 1. Transmissibility of systemic amyloidosis by a prion-like mechanism.
    Lundmark K; Westermark GT; Nyström S; Murphy CL; Solomon A; Westermark P
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6979-84. PubMed ID: 12011456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of amyloid-enhancing factor (AEF): study on experimental murine AA amyloidosis.
    Omoto M; Yokota T; Cui D; Hoshii Y; Kawano H; Gondo T; Ishihara T; Kanda T
    Med Mol Morphol; 2007 Jun; 40(2):88-94. PubMed ID: 17572844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusible amyloid oligomers trigger systemic amyloidosis in mice.
    Senthilkumar S; Chang E; Jayakumar R
    Biochem J; 2008 Oct; 415(2):207-15. PubMed ID: 18564059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of circulating cell-free AA amyloid oligomers in exosomes vectors via a prion-like mechanism.
    Tasaki M; Ueda M; Ochiai S; Tanabe Y; Murata S; Misumi Y; Su Y; Sun X; Shinriki S; Jono H; Shono M; Obayashi K; Ando Y
    Biochem Biophys Res Commun; 2010 Oct; 400(4):559-62. PubMed ID: 20807507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
    Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
    Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of systemic AA amyloidosis in animals.
    Murakami T; Ishiguro N; Higuchi K
    Vet Pathol; 2014 Mar; 51(2):363-71. PubMed ID: 24280941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid enhancing factor and dietary transmission in accelerated amyloid A amyloidosis.
    Elliott-Bryant R; Cathcart ES
    Clin Immunol Immunopathol; 1998 Jul; 88(1):65-9. PubMed ID: 9683551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloidogenic potential of foie gras.
    Solomon A; Richey T; Murphy CL; Weiss DT; Wall JS; Westermark GT; Westermark P
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10998-1001. PubMed ID: 17578924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
    Sørby R; Espenes A; Landsverk T; Westermark G
    Amyloid; 2008 Mar; 15(1):20-8. PubMed ID: 18266118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT; Westermark P
    FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism.
    Lundmark K; Westermark GT; Olsén A; Westermark P
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6098-102. PubMed ID: 15829582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-enhancing factor (AEF) in the pathogenesis of AA-amyloidosis in the hamster.
    Hol PR; Snel FW; Niewold TA; Gruys E
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(3):273-81. PubMed ID: 2879382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-seeding and cross-competition in mouse apolipoprotein A-II amyloid fibrils and protein A amyloid fibrils.
    Yan J; Fu X; Ge F; Zhang B; Yao J; Zhang H; Qian J; Tomozawa H; Naiki H; Sawashita J; Mori M; Higuchi K
    Am J Pathol; 2007 Jul; 171(1):172-80. PubMed ID: 17591964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
    Ailles L; Kisilevsky R; Young ID
    Lab Invest; 1993 Oct; 69(4):443-8. PubMed ID: 8231112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic AA amyloidosis as a prion-like disorder.
    Murakami T; Inoshima Y; Ishiguro N
    Virus Res; 2015 Sep; 207():76-81. PubMed ID: 25533533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils.
    Johan K; Westermark G; Engström U; Gustavsson A; Hultman P; Westermark P
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2558-63. PubMed ID: 9482925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid enhancing factor is produced by rats and amyloid-resistant CE/J mice.
    Gonnerman WA; Kandel R; Cathcart ES
    Lab Invest; 1996 Jan; 74(1):259-64. PubMed ID: 8569190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of heating on the stability of amyloid A (AA) fibrils and the intra- and cross-species transmission of AA amyloidosis.
    Ogawa S; Murakami T; Inoshima Y; Ishiguro N
    Amyloid; 2015; 22(4):236-43. PubMed ID: 26588017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice.
    Ganowiak K; Hultman P; Engström U; Gustavsson A; Westermark P
    Biochem Biophys Res Commun; 1994 Feb; 199(1):306-12. PubMed ID: 8123028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AA-amyloidosis can be transferred by peripheral blood monocytes.
    Sponarova J; Nyström SN; Westermark GT
    PLoS One; 2008 Oct; 3(10):e3308. PubMed ID: 18830411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.